erythromycin ethylsuccinate and Mycoplasma dispar Infection

erythromycin ethylsuccinate has been researched along with Mycoplasma dispar Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Block, S; Cassell, GH; Craft, JC; Hammerschlag, MR; Hedrick, J1

Trials

1 trial(s) available for erythromycin ethylsuccinate and Mycoplasma dispar Infection

ArticleYear
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
    The Pediatric infectious disease journal, 1995, Volume: 14, Issue:6

    Topics: Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Erythromycin Ethylsuccinate; Female; Humans; Male; Pneumonia, Mycoplasma; Prospective Studies; Treatment Outcome

1995